{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:51:35Z","timestamp":1789739495547,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.phro.2026.100941","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:08:13Z","timestamp":1772557693000},"page":"100941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of intra- and interfractional motion on the dose distribution and urinary adverse events for magnetic resonance-guided prostate cancer radiotherapy"],"prefix":"10.1016","volume":"38","author":[{"given":"Shu","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Burleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Hassan-Razein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergys","family":"Subashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2026.100941_b0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate Cancer Incidence and mortality: an update","volume":"87","author":"Schafer","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.phro.2026.100941_b0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11912-017-0584-7","article-title":"The role of hypofractionated radiotherapy in prostate cancer","volume":"19","author":"Benjamin","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.phro.2026.100941_b0015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2026.100941_b0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fonc.2020.00539","article-title":"Clinical assessment of prostate displacement and planning target volume margins for stereotactic body radiotherapy of prostate cancer","volume":"10","author":"Levin-Epstein","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.phro.2026.100941_b0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ijrobp.2007.10.049","article-title":"Dosimetric consequences of intrafraction prostate motion","volume":"71","author":"Li","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.100941_b0030","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.ijrobp.2009.05.022","article-title":"Gains from real-time tracking of prostate motion during external beam radiation therapy","volume":"75","author":"Li","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.100941_b0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2021.05.004","article-title":"Reproducibility and accuracy of a target motion mitigation technique for dose-escalated prostate stereotactic body radiotherapy","volume":"160","author":"Greco","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.100941_b0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.phro.2019.02.002","article-title":"Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer","volume":"9","author":"Tetar","year":"2019","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2026.100941_b0045","first-page":"1","article-title":"Prostate motion in magnetic resonance imaging-guided radiotherapy and its impact on margins","author":"Kusters","year":"2025","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.phro.2026.100941_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2022.09.007","article-title":"Magnetic resonance-guided adaptive radiation therapy for prostate cancer: the first results from the MOMENTUM study-an international registry for the evidence-based introduction of magnetic resonance-guided adaptive radiation therapy","volume":"13","author":"Teunissen","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.phro.2026.100941_b0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2022.03.013","article-title":"Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer","volume":"170","author":"Wahlstedt","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.100941_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020270","article-title":"MR-LINAC, a new partner in radiation oncology: current landscape","volume":"16","author":"Ocanto","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.phro.2026.100941_b0065","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00066-018-1286-2","article-title":"Shorter treatment times reduce the impact of intra-fractional motion : a real-time 4DUS study comparing VMAT vs. step-and-shoot IMRT for prostate cancer","volume":"194","author":"Ballhausen","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.phro.2026.100941_b0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijrobp.2013.02.035","article-title":"Prostate and patient intrafraction motion: impact on treatment time-dependent planning margins for patients with endorectal balloon","volume":"86","author":"Steiner","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.100941_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.109441","article-title":"SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: an analysis of the dosimetric impact of intra-fractional organ changes","volume":"179","author":"Brennan","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.100941_b0080","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1088\/0031-9155\/60\/2\/549","article-title":"Intra-fraction motion of the prostate is a random walk","volume":"60","author":"Ballhausen","year":"2015","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2026.100941_b0085","doi-asserted-by":"crossref","unstructured":"de Muinck Keizer DM, Kerkmeijer LGW, Maspero M, Andreychenko A, van der Voort van Zyp JRN, van den Berg CAT, et al. Soft-tissue prostate intrafraction motion tracking in 3D cine-MR for MR-guided radiotherapy. Phys Med Biol 2019;64:235008. https:\/\/doi.org\/10.1088\/1361-6560\/ab5539.","DOI":"10.1088\/1361-6560\/ab5539"},{"key":"10.1016\/j.phro.2026.100941_b0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1756-6649-13-4","article-title":"Real-time prostate motion assessment: image-guidance and the temporal dependence of intra-fraction motion","volume":"13","author":"Cramer","year":"2013","journal-title":"BMC Med Phys"},{"key":"10.1016\/j.phro.2026.100941_b0095","doi-asserted-by":"crossref","unstructured":"Kontaxis C, de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, den Hartogh MD, van der Voort van Zyp JRN, et al. Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5T magnetic resonance imaging and linear accelerator system. Phys Imaging Radiat Oncol 2020;15:23\u20139. https:\/\/doi.org\/10.1016\/j.phro.2020.06.005.","DOI":"10.1016\/j.phro.2020.06.005"},{"key":"10.1016\/j.phro.2026.100941_b0100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijrobp.2008.04.051","article-title":"Intrafractional motion of the prostate during hypofractionated radiotherapy","volume":"72","author":"Xie","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.100941_b0105","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ijrobp.2012.05.044","article-title":"Relationship of imaging frequency and planning margin to account for intrafraction prostate motion: analysis based on real-time monitoring data","volume":"85","author":"Curtis","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.100941_b0110","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2007.11.054","article-title":"Observations on real-time prostate gland motion using electromagnetic tracking","volume":"71","author":"Langen","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.100941_b0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tipsro.2022.08.005","article-title":"Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac","volume":"23","author":"Dang","year":"2022","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.phro.2026.100941_b0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/COC.0b013e31819fdf7c","article-title":"Cine-magnetic resonance imaging assessment of intrafraction motion for prostate cancer patients supine or prone with and without a rectal balloon","volume":"33","author":"Vargas","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.phro.2026.100941_b0125","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0360-3016(02)03008-0","article-title":"Measurement of intrafractional prostate motion using magnetic resonance imaging","volume":"54","author":"Mah","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.100941_b0130","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/cancers15041153","article-title":"Dosimetric impact of intrafraction prostate motion and interfraction anatomical changes in dose-escalated linac-based SBRT","volume":"15","author":"Faccenda","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.phro.2026.100941_b0135","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1118\/1.3679859","article-title":"Irradiation of the prostate and pelvic lymph nodes with an adaptive algorithm: adaptive prostate radiotherapy","volume":"39","author":"Hwang","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2026.100941_b0140","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00066-022-02005-1","article-title":"Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gating","volume":"199","author":"Xiong","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.phro.2026.100941_b0145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic resonance imaging-guided vs computed tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: the MIRAGE randomized clinical trial: the MIRAGE randomized clinical trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol"},{"issue":"430","key":"10.1016\/j.phro.2026.100941_b0150","first-page":"e1","article-title":"Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: a secondary analysis of RTOG 94-08 and 96-01","volume":"34","author":"Mak","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.phro.2026.100941_b0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijrobp.2020.09.054","article-title":"Prostate stereotactic body radiation therapy: an overview of toxicity and dose response","volume":"110","author":"Wang","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.100941_b0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejmp.2021.11.004","article-title":"Machine log file-based dose verification using novel iterative CBCT reconstruction algorithm in commercial software during volumetric modulated arc therapy for prostate cancer patients","volume":"92","author":"Inui","year":"2021","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2026.100941_b0165","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14594","article-title":"Automated daily dose accumulation workflow for treatment quality assurance during online adaptive radiotherapy with a 0.35T MR-linac","volume":"26","author":"Behzadipour","year":"2025","journal-title":"J Appl Clin Med Phys"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626000412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626000412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:48:03Z","timestamp":1778881683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631626000412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"alternative-id":["S2405631626000412"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2026.100941","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of intra- and interfractional motion on the dose distribution and urinary adverse events for magnetic resonance-guided prostate cancer radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2026.100941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100941"}}